RT Journal Article
SR Electronic
T1 ePOCT+ and the medAL-suite: Development of an electronic clinical decision support algorithm and digital platform for pediatric outpatients in low- and middle-income countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.02.22279524
DO 10.1101/2022.09.02.22279524
A1 Tan, Rainer
A1 Cobuccio, Ludovico
A1 Beynon, Fenella
A1 Levine, Gillian
A1 Vaezipour, Nina
A1 Luwanda, Lameck
A1 Mangu, Chacha
A1 Vonlanthen, Alan
A1 Santis, Olga De
A1 Salim, Nahya
A1 Manji, Karim
A1 Naburi, Helga
A1 Chirande, Lulu
A1 Matata, Lena
A1 Bulongeleje, Method
A1 Moshiro, Robert
A1 Miheso, Andolo
A1 Arimi, Peter
A1 Ndiaye, Ousmane
A1 Faye, Moctar
A1 Thiongane, Aliou
A1 Awasthi, Shally
A1 Sharma, Kovid
A1 Kumar, Gaurav
A1 Van De Maat, Josephine
A1 Kulinkina, Alexandra
A1 Rwandarwacu, Victor
A1 Dusengumuremyi, Théophile
A1 Nkuranga, John Baptist
A1 Rusingiza, Emmanuel
A1 Tuyisenge, Lisine
A1 Hartley, Mary-Anne
A1 Faivre, Vincent
A1 Thabard, Julien
A1 Keitel, Kristina
A1 D’Acremont, Valérie
YR 2022
UL http://medrxiv.org/content/early/2022/09/04/2022.09.02.22279524.abstract
AB Electronic clinical decision support algorithms (CDSAs) have been developed to address high childhood mortality and inappropriate antibiotic prescription by helping clinicians adhere to guidelines. Previously identified challenges of CDSAs include its limited scope, usability, and outdated clinical algorithms. To address these challenges we developed ePOCT+, a CDSA for the care of pediatric outpatients in low- and middle-income settings, and the medical algorithm suite (medAL-suite), a software for the creation and execution of CDSAs. Following the principles of digital development, we aim to describe the process and lessons learnt from the development of ePOCT+ and the medAL-suite.In particular, this work outlines the systematic integrative development process in the design and implementation of these tools required to meet the needs of clinicians to improve uptake and quality of care. We considered the feasibility, acceptability and reliability of clinical signs and symptoms, as well as the diagnostic and prognostic performance of predictors. To assure clinical validity, and appropriateness for the country of implementation the algorithm underwent numerous reviews by clinical experts and health authorities from the implementing countries. The digitalization process involved the creation of medAL-creator, a digital platform which allows clinicians without IT skills to easily create the algorithms, and medAL-reader the mobile health (mHealth) app used by clinicians during the consultation. Extensive feasibility tests were done with feedback from end-users of multiple countries to improve the clinical algorithm and medAL-reader software.We hope that the development framework used for developing ePOCT+ will help support the development of other CDSAs, and that the open-source medAL-suite will enable others to easily and independently implement them.AUTHOR SUMMARY In accordance with the principles of digital development we describe here the process and lessons learnt from the development of ePOCT+, a clinical decision support algorithm (CDSA), and the medAL-suite software, to program and implement CDSAs.The clinical algorithm was adapted from previous CDSAs in order to address challenges in regards to the limited scope of illnesses and patient population addressed, the ease of use, and limited performance of specific algorithms. Adaptations and improvements to the clinical algorithm was developed based on considerations of what symptoms and signs would be appropriate for primary care level health care workers, and how well these clinical elements are at predicting a particular disease or severe outcome. We hope that by sharing our multi-stakeholder approach to the development of ePOCT+, it can help others in the development of other CDSAs.The medAL-creator software was developed to allow clinicians without IT programming experience to program the clinical algorithm using a drag-and-drop interface, which we hope allows a wider range of health authorities and implementers to develop and adapt their own CDSA. The medAL-reader application, deploys the algorithm from medAL-creator to end-users following the usual healthcare processes of a consultation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work took place within the framework of the DYNAMIC project that is funded by the Fondation Botnar, Switzerland (grant n 6278) as well as the Swiss Development Cooperation (grant n 7F-10361.01.01) received by VDA. The TIMCI project funded by UNITAID (grant n 2019-35-TIMCI) received by VDA allowed for adapting of ePOCT+ or the medAL-suite software to Senegal, Kenya and India. The funders had no role in the development of ePOCT+ or the medAL-suite software, data collection, analysis, nor did they have a role in the decision to publish, or preparation of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Ifakara Health Institute in Tanzania, the National Institute for Medical Research in Tanzania, the National Ethics Committee of Rwanda, the Comite National d Ethique pour la Recherche en Sante of Senegal, the University of Nairobi Ethics and Research Committee in Kenya, the King George s Medical College Institutional Ethics Committee in India, the Indian Council of Medical Research, the cantonal ethics review board of Vaud, Switzerland, and the WHO Ethics Review Committee, the Ethikkommission Beider Basel in Switzerland, and the Boston Children s Hospital, all gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are available upon reasonable request to the authors.